Ziegfeld Ballroom
141 W 54th St., NYC
6 PM - Cocktails
7 PM - Dinner and Program
Together As One
53rd Gala
March 6th, 2026
United in purpose, empowered to serve.
Together as One celebrates the unity, resilience, and shared purpose that define our community. For over five decades, KCS has brought people together across generations, cultures, and experiences to create lasting change. This year’s theme honors the power of collective strength - how, when we come together as one, we uplift each other, bridge divides, and build a more compassionate and inclusive society. As we reflect on our journey and look to the future, Together as One reminds us that our progress is only possible through the connections that bind us and the shared hope that drives us forward.
HONOREES
Julie Kim
Julie Kim was appointed by the Takeda Board of Directors to succeed Christophe Weber as president & CEO of Takeda in June 2026. She recently completed her tenure as president of the U.S. Business Unit and U.S. country head, where she managed the company’s largest business unit. As part of her transition to CEO, she will also serve as interim head of the Global Portfolio Division. Julie joined Takeda through the 2019 acquisition of Shire and served as president of the Plasma-Derived Therapies Business Unit. With three decades of experience in health care, Julie’s leadership spans global, regional, and country-level roles across a variety of therapeutic areas and markets. Renowned for her collaborative and inclusive approach, she is committed to serving patients and advancing innovation. She holds an MBA from Northwestern University’s Kellogg School of Management and a bachelor’s degree in economics from Dartmouth College.
Ken Song
Ken Song, M.D. is Chairman, President and CEO of Candid Therapeutics, a clinical stage biotech company focused on leading the field of deep B-cell depletion using T-cell engagers to treat autoimmune diseases. He has over 25 years of combined entrepreneurship, investing, clinical medicine, and research experience. As an entrepreneur, he has been CEO or Executive Chairman of RayzeBio, Ariosa Diagnostics, Omniome, Metacrine, and Ablaze Pharmaceuticals, all of which have led to successful outcomes and collectively with RayzeBio provided over $5.5B in realized value to shareholders. He also currently serves as executive chairman of Averto Medical, board director at Perceptive Capital Solutions Corp, and board director at ElevAAte, a non-profit organization for East Asian American leadership in biopharma. Earlier in his career, Ken was a venture capitalist at Venrock and a consultant at McKinsey & Company. Ken received a B.S. in biology from MIT and an M.D. from UCSF. Ken trained in internal medicine at UCSF and gastroenterology and hepatology at the University of Washington, and was a scientific research fellow at the Fred Hutchinson Cancer Center.
GALA CHAIRS
Isabella Park
Physician Partner
Northwell Health
Gene Kang
Partner
Rivkin Radler LLP
HOST COMMITEE
Karen Choi
Partner and Portfolio Manager, Capital Group Companies
Board Member, New York Women’s Foundation
Board Member, Horace Mann School Board of Trustees​
​
Sandra Schubert
Managing Director, GS Private Wealth
Board Member, Korean Finance Society (KFS);
Board Member, Brooklyn Public Library
​
Jumee Song
COO, Seigel Family Endowment
Fulbright Specialist at Asan Nanum Foundation
Board Member, Korean American Community Foundation (KACF)
​
Leighanne Oh
VP, Ascenta Capital
Executive Committee, Korean Finance Society (KFS)
​
Jennifer Wu
Founding Partner, Groombridge, Wu, Baughman & Stone LLP
SPONSORS
DIAMOND
Karen & Samuel Choi
PLATINUM
